Parthenon LLC’s Amgen AMGN Stock Holding History

Parthenon LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,177	Closed	-$414K	–	134
2026 Q1	$414K	Hold	1,177	–	–	0.05%	103
2025 Q4	$385K	Hold	1,177	–	–	0.04%	104
2025 Q3	$332K	Hold	1,177	–	–	0.04%	106
2025 Q2	$329K	Hold	1,177	–	–	0.04%	105
2025 Q1	$367K	Hold	1,177	–	–	0.05%	100
2024 Q4	$307K	Hold	1,177	–	–	0.04%	103
2024 Q3	$379K	Hold	1,177	–	–	0.05%	101
2024 Q2	$368K	Hold	1,177	–	–	0.05%	96
2024 Q1	$335K	Hold	1,177	–	–	0.04%	100
2023 Q4	$339K	Sell	1,177 -50	-4%	-$13.6K	0.05%	100
2023 Q3	$330K	Hold	1,227	–	–	0.05%	98
2023 Q2	$272K	Buy	1,227 +50	+4%	+$11.6K	0.04%	105
2023 Q1	$285K	Hold	1,177	–	–	0.04%	104
2022 Q4	$309K	Hold	1,177	–	–	0.05%	98
2022 Q3	$265K	Hold	1,177	–	–	0.05%	98
2022 Q2	$286K	Hold	1,177	–	–	0.05%	99
2022 Q1	$285K	Hold	1,177	–	–	0.04%	103
2021 Q4	$265K	Hold	1,177	–	–	0.04%	108
2021 Q3	$250K	Sell	1,177 -224	-16%	-$51.6K	0.04%	110
2021 Q2	$341K	Buy	1,401 +224	+19%	+$55.1K	0.05%	104
2021 Q1	$293K	Sell	1,177 -35	-3%	-$8.35K	0.05%	105
2020 Q4	$279K	Sell	1,212 -1,302	-52%	-$300K	0.05%	108
2020 Q3	$639K	Buy	2,514 +1,250	+99%	+$310K	0.12%	77
2020 Q2	$298K	Hold	1,264	–	–	0.06%	89
2020 Q1	$256K	Sell	1,264 -59	-4%	-$12.9K	0.06%	94
2019 Q4	$319K	Hold	1,323	–	–	0.06%	96
2019 Q3	$256K	Sell	1,323 -40	-3%	-$7.68K	0.05%	95
2019 Q2	$251K	Hold	1,363	–	–	0.05%	98
2019 Q1	$259K	Sell	1,363 -6	-0.4%	-$1.15K	0.06%	98
2018 Q4	$267K	Buy	1,369 +65	+5%	+$12.7K	0.07%	92
2018 Q3	$270K	Sell	1,304 -80	-6%	-$15.8K	0.06%	95
2018 Q2	$255K	Hold	1,384	–	–	0.06%	96
2018 Q1	$236K	Sell	1,384 -180	-12%	-$33K	0.06%	98
2017 Q4	$272K	Sell	1,564 -588	-27%	-$104K	0.06%	96
2017 Q3	$401K	Sell	2,152 -75	-3%	-$13.3K	0.09%	81
2017 Q2	$384K	Hold	2,227	–	–	0.09%	85
2017 Q1	$365K	Hold	2,227	–	–	0.09%	88
2016 Q4	$326K	Buy	2,227 +80	+4%	+$12K	0.08%	91
2016 Q3	$358K	Hold	2,147	–	–	0.09%	87
2016 Q2	$327K	Hold	2,147	–	–	0.08%	89
2016 Q1	$322K	Hold	2,147	–	–	0.08%	87
2015 Q4	$349K	Hold	2,147	–	–	0.09%	85
2015 Q3	$297K	Hold	2,147	–	–	0.08%	88
2015 Q2	$330K	Sell	2,147 -30	-1%	-$4.81K	0.09%	88
2015 Q1	$348K	Buy	2,177 +262	+14%	+$41.3K	0.09%	83
2014 Q4	$305K	Buy	1,915 +50	+3%	+$7.79K	0.08%	82
2014 Q3	$262K	Hold	1,865	–	–	0.08%	82
2014 Q2	$221K	Hold	1,865	–	–	0.07%	83
2014 Q1	$230K	Hold	1,865	–	–	0.07%	84
2013 Q4	$213K	Hold	1,865	–	–	0.07%	86
2013 Q3	$209K	Buy	+1,865	New	+$202K	0.07%	83

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Parthenon LLC's AMGN Position: Q2 2026 in Review

Parthenon LLC sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,177 shares — an estimated $414K sold.

Parthenon LLC first reported a position in AMGN in Q3 2013 and held it in 51 quarters. The position peaked at $639K in Q3 2020. 1,413 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Parthenon LLC reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Parthenon LLC sold 1,177 Amgen shares in Q2 2026, an estimated $414K.
Parthenon LLC first reported a position in Amgen in Q3 2013 and held it in 51 quarters.
Parthenon LLC's Amgen position peaked at $639K in Q3 2020.
1,413 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.